Corporate News 02-Nov-23
Shilpa Medicare acquires US-based Pilnova Pharma
Shilpa Medicare has acquired "Pilnova Pharma, Inc" in the United States on 02 November 2023 which shall be a wholly owned subsidiary of Shilpa Medicare.
Previous News
Shilpa Medicare announces board meeting date
( Corporate News - 02-Feb-24 14:39 )
Shilpa Medicare announces board meeting date
( Corporate News - 16-May-24 16:56 )
Shilpa Medicare AGM scheduled
( Corporate News - 05-Sep-23 15:26 )
Shilpa Medicare consolidated net profit rises 24.77% in the December 2021 quarter
( Results - Announcements 08-Feb-22 16:35 )
Shilpa Medicare consolidated net profit rises 277.39% in the March 2022 quarter
( Results - Announcements 23-May-22 17:38 )
Shilpa Medicare to convene board meeting
( Corporate News - 17-May-22 14:16 )
Board of Shilpa Medicare approves transfer of API biz to a new subsidiary
( Corporate News - 12-Jul-21 18:13 )
Shilpa Medicare standalone net profit rises 8.30% in the September 2019 quarter
( Results - Announcements 11-Nov-19 11:09 )
Shilpa Medicare consolidated net profit rises 20.13% in the September 2019 quarter
( Results - Announcements 11-Nov-19 12:04 )
Shilpa Medicare to conduct board meeting
( Corporate News - 04-Nov-22 15:38 )
Shilpa Medicare standalone net profit declines 54.08% in the March 2021 quarter
( Results - Announcements 31-May-21 16:04 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
